Table 2.
Parameter values: medical costs and earnings loss due to filarial lymphedema and ADLA
| Parameter | Baseline estimate in January 2018* | Sources |
|---|---|---|
| Annual per-person out-of-pocket medical costs for chronic filarial lymphedema | US$10.09 | 32,33 |
| Per-episode out-of-pocket medical costs for ADLA | US$1.23 | 31,34,35 |
| Average duration of ADLA (lost work days) | 4 days | 34,63–70 |
| Annual increase in real cost of medical care for chronic lymphedema and ADLA | 3% | 71–76 |
| Annual discount rate | 3% | 47 |
| Average daily wage rate | US$3.87 | 40,41,46 |
| Annual increase in real wages | 2.7% | 41,71–84 |
| Average number of days worked per year | 260 | |
| Percentage of work days lost annually because of chronic lymphedema | 32,33,49,50,69,85 | |
| Stages 1–2 | 0% | |
| Stage 3 | 20% | |
| Stage 4 | 50% | |
| Stages 5–6 | 75% | |
| Stage 7 | 100% | |
ADLA = acute dermatolymphangioadenitis.
Derivation of values is explained in the Supplement.